The Cost-Effectiveness of the Kiva Antibullying Program: Results from a Decision-Analytic Model

被引:0
|
作者
Mattias Persson
Linn Wennberg
Linda Beckman
Christina Salmivalli
Mikael Svensson
机构
[1] Örebro University,Department of Economics, School of Business
[2] University of Gothenburg,Department of Public Health & Community Medicine
[3] Karlstad University,Department of Public Health
[4] University of Turku,Department of Psychology
[5] University of Gothenburg,Health Metrics, The Sahlgrenska Academy
来源
Prevention Science | 2018年 / 19卷
关键词
Cost-effectiveness; KiVa; Bullying prevention program; Decision modeling;
D O I
暂无
中图分类号
学科分类号
摘要
Bullying causes substantial suffering for children and adolescents. A number of bullying prevention programs have been advocated as effective methods for counteracting school bullying. However, there is a lack of economic evaluations of bullying prevention programs assessing the “value for money.” The aim of this study was to assess the cost-effectiveness of the Finnish bullying prevention program KiVa in comparison to “status quo” (treatment as usual) in a Swedish elementary school setting (grades 1 to 9). The cost-effectiveness analysis was carried out using a payer perspective based on a Markov cohort model. The costs of the program were measured in Swedish kronor and Euros, and the benefits were measured using two different metrics: (1) the number of victim-free years and (2) the number of quality adjusted life years (QALYs). Data on costs, probability transitions, and health-related quality of life measures were retrieved from published literature. Deterministic and probabilistic sensitivity analyses were carried out to establish the uncertainty of the cost-effectiveness results. The base-case analysis indicated that KiVa leads to an increased cost of €829 for a gain of 0.47 victim-free years per student. In terms of the cost per gained QALY, the results indicated a base-case estimate of €13,823, which may be seen as cost-effective given that it is lower than the typically accepted threshold value in Swedish health policy of around €50,000. Further research is needed to confirm the conclusions of this study, especially regarding the treatment effects of KiVa in different school contexts.
引用
收藏
页码:728 / 737
页数:9
相关论文
共 50 条
  • [1] The Cost-Effectiveness of the Kiva Antibullying Program: Results from a Decision-Analytic Model
    Persson, Mattias
    Wennberg, Linn
    Beckman, Linda
    Salmivalli, Christina
    Svensson, Mikael
    PREVENTION SCIENCE, 2018, 19 (06) : 728 - 737
  • [2] Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model
    Fiddelers, Audrey A. A.
    Dirksen, Carmen D.
    Dumoulin, John C. M.
    van Montfoort, Aafke P. A.
    Land, Jolande A.
    Janssen, J. Marij
    Evers, Johannes L. H.
    Severens, Johan L.
    HUMAN REPRODUCTION, 2009, 24 (07) : 1648 - 1655
  • [3] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    Ramos, G. Feljandro P.
    van Asselt, Antoinette D. I.
    Kuiper, Sandra
    Severens, Johan L.
    Maas, Tanja
    Dompeling, Edward
    Knottnerus, J. Andre
    van Schayck, Onno C. P.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (08): : 869 - 883
  • [4] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A
  • [5] COST-EFFECTIVENESS OF TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION: A DECISION-ANALYTIC MODEL
    Amin, Amit P.
    Marso, Steven P.
    Chhatriwalla, Adnan
    Safley, David
    Kennedy, Kevin
    House, John
    Mills, Rebecca
    Salisbury, Adam
    Spertus, John
    Cohen, David
    Baklanov, Dmitri
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E338 - E338
  • [6] COST-EFFECTIVENESS OF MATERNAL TOXOPLASMA SCREENING IN AUSTRIA: A DECISION-ANALYTIC MODEL
    Prusa, A. R.
    Walter, E.
    Pollak, A.
    Hayde, M.
    Kasper, D. C.
    VALUE IN HEALTH, 2013, 16 (07) : A333 - A333
  • [7] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    G. Feljandro P. Ramos
    Antoinette D. I. van Asselt
    Sandra Kuiper
    Johan L. Severens
    Tanja Maas
    Edward Dompeling
    J. André Knottnerus
    Onno C. P. van Schayck
    The European Journal of Health Economics, 2014, 15 : 869 - 883
  • [8] Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with AML
    Horster, L.
    Wasem, J.
    Ganser, A.
    Stadler, M.
    Schlenk, Rf
    Port, M.
    Gabriel, M.
    Schildmann, J.
    Rochau, U.
    Sroczynski, G.
    GESUNDHEITSWESEN, 2015, 77
  • [9] OVERVIEW ON COST-EFFECTIVENESS RESULTS OF DECISION-ANALYTIC STUDIES FOR THE TREATMENT OF MULTIPLE MYELOMA
    Rochau, U.
    Jahn, B.
    Qerimi, V
    Kluibenschaedl, M.
    Kurzthaler, C.
    Conrads-Frank, A.
    Willenbacher, W.
    Gastl, G.
    Siebert, U.
    VALUE IN HEALTH, 2013, 16 (07) : A410 - A411
  • [10] A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet
    Björn Stollenwerk
    Sergio Iannazzo
    Ron Akehurst
    Michael Adena
    Andrew Briggs
    Bastian Dehmel
    Patrick Parfrey
    Vasily Belozeroff
    PharmacoEconomics, 2018, 36 : 603 - 612